Radiation-induced Adenovirus Vector Construction Service
Adenovirus-mediated gene therapy combined with radiation is expected to be an attractive approach to treat cancer. Creative Biolabs is a leading expert in adenovirus vector construction for gene delivery and gene therapy applications. Equipped with powerful viral vector construction technologies and experienced expert team, we provide excellent adenovirus vector construction service to meet your various needs.
Background of Radiation-induced Adenoviral Vectors
Several strategies of gene therapy of tumors are currently under investigation, including the transfer of genes that regulate growth and induce an antitumor immune response. Adenoviral vectors have been chosen as effective delivery vehicles for therapeutic genes. However, they have limited effectiveness due to the poor level of tumor cell transduction and potential toxicity. Previous reports have found that radiation can increase the antitumor effect of replication-defective adenoviruses by enhancing adenoviral transgene expression both in vitro and in vivo. Radiation-induced enhancement of adenoviral transgene expression is mediated through DNA damage, specifically double-strand DNA break. The radiation-induced DNA damage response results in increased production of RNA and proteins, including adenoviral transgene products.
Figure 1. Radiation causes a fatal double-strand break. DNA damage repair is mediated by two major pathways: homologous recombination repair (HRR) and non-homologous end joining (NHEJ).1
Radiation-induced Adenoviral Vectors in Gene Therapy
Radiotherapy is an important method for the clinical treatment of many cancers, but its therapeutic effect is often affected by damage to the surrounding normal tissues and tumor radiation tolerance. Therefore, radiotherapy alone has certain limitations. Gene-radiotherapy, as a new therapy combining gene therapy and radiation therapy, has aroused great interest and has broad application prospects. The basic principle of gene-radiotherapy is to use the radiation-induced characteristics of early growth response-1 (Egr-1) to increase the expression of a target gene following radiation and thereby enhance the treatment effect. Since their first use in gene therapy, adenoviral vectors have made significant progress and are currently undergoing clinical trials in several gene therapies and anti-cancer studies. The efficient expression of radiation-inducible therapeutic genes in cancer cells is crucial in gene-radiotherapy. The combination of adenoviral cancer gene therapy and radiotherapy is a promising approach that exhibits several advantages:
- This combination could lead to increased tumor control without an increase in toxicity owing to a nonoverlapping side effect profile.
- This combination increases the level of transgene expression in cancer cells and shows better therapeutic effects.
Why Choose Radiation-Induced Adenovirus Vectors?
Radiation-inducible adenoviral vectors represent a highly strategic approach for controlled gene therapy, especially in oncology settings where radiotherapy is already part of standard treatment.
Key Advantages
-
Spatially Controlled Expression
Gene expression is confined to irradiated tissues, enabling localized therapeutic effects. -
On-Demand Activation
Expression can be triggered precisely when needed, offering temporal flexibility. -
Enhanced Tumor Selectivity
When combined with radiotherapy, gene activation is preferentially restricted to tumor sites. -
Reduced Systemic Toxicity
Minimizing gene expression in non-target tissues improves safety profiles. -
High Transduction Efficiency
Adenoviral vectors enable robust gene delivery across dividing and non-dividing cells. -
Synergistic Therapeutic Potential
Radiation and gene therapy can act synergistically to enhance anti-tumor effects.
These advantages make radiation-induced adenoviral vectors particularly suitable for cancer gene therapy, radiosensitization strategies, and precision therapeutic interventions.
Mechanism of Radiation-Inducible Gene Expression
Radiation-induced gene expression is driven by cellular responses to ionizing radiation. The mechanism can be summarized as follows:
-
Radiation Exposure
Cells are exposed to ionizing radiation, causing DNA damage and oxidative stress. -
Activation of Signaling Pathways
Key pathways such as MAPK, NF-κB, and p53 are activated. -
Promoter Activation
Radiation-responsive promoters (e.g., Egr-1, NF-κB) are activated by transcription factors. -
Transgene Expression
The downstream therapeutic gene is transcribed and translated. -
Biological Effect
The expressed protein exerts its intended therapeutic or experimental function.
This tightly regulated process enables precise control over gene expression in response to external radiation stimuli.
Our Adenovirus Vector Construction Services
Radiation can enhance adenoviral vector-mediated gene therapy by increasing the expression of the transgene. This effect can be achieved by using a radiation-inducible promoter/enhancer, as it opens up the possibility of placing gene expression under the spatial and temporal control of radiation. The feasibility of this new method has been confirmed in different tumor models. Based on this, Creative Biolabs has provided a wide variety of radiation-inducible adenoviral vectors for customers around the world through the use of suitable promoters and other elements. Compared to traditional vectors, our radiation-induced adenoviral vectors have higher gene transduction efficiency and very low toxicity, and show broader prospects in gene delivery and gene therapy applications.
01. Customized Vector Design
- Selection and optimization of radiation-responsive promoters
- Design of transgene expression cassettes
- Promoter sensitivity tuning for different radiation doses
- Incorporation of regulatory elements for enhanced expression control
02. Adenoviral Backbone Engineering
- Construction of E1/E3-deleted adenoviral vectors for safety
- Development of replication-deficient or conditionally replicative systems
- Payload optimization for large or complex gene constructs
03. Vector Construction and Packaging
- High-efficiency cloning and recombination
- Packaging in HEK293 or other suitable cell lines
- Production of high-titer viral stocks
04. Functional Validation
- Radiation induction assays to confirm responsiveness
- Expression kinetics and dose-response analysis
- Quantitative evaluation of transgene expression
05. In Vitro and In Vivo Evaluation
- Cell-based irradiation experiments
- Tumor xenograft model validation
- Spatial expression analysis in irradiated tissues
Types of Radiation-Inducible Systems We Offer
We provide multiple radiation-responsive systems to meet diverse experimental and therapeutic needs:
| System Type | Features | Applications |
|---|---|---|
| Egr-1 promoter-based system | Highly responsive to radiation | Cancer gene therapy |
| NF-κB-responsive system | Stress and inflammation responsive | Immune modulation |
| Synthetic radiation promoters | Tunable sensitivity and specificity | Precision medicine |
| Dual-control systems | Radiation + tumor-specific regulation | Advanced targeting strategies |
These options allow for flexible customization based on your project requirements.
Technical Workflow & Delivery
Our structured workflow ensures transparency and rapid turnaround for your research milestones.
| Phase | Description | Delivery |
|---|---|---|
| I. Design | Sequence optimization, codon optimization, and promoter synthesis. | Design Report & Plasmid Maps |
| II. Construction | Recombination into AdEasy or AdMax systems; sequence verification. | Verified Shuttle & Backbone Plasmids |
| III. Packaging | P1-P3 amplification in HEK293 or specialized producer lines. | Primary Viral Stock |
| IV. Purification | CsCl ultracentrifugation or HPLC-based purification. | High-Titer Purified Virus |
| V. Validation | Titering (IFU/VP), Endotoxin, and IR-Induction testing. | Comprehensive QC Report |
Quality Control: Meeting Global Regulatory Standards
Every batch of Radiation-Induced Adenovirus undergoes rigorous testing:
- Physical Titer (VP/mL): Determined by OD260.
- Infectious Titer (IFU/mL): Determined by TCID50 or plaque assay.
- Purity: VP/IFU ratio < 30; Endotoxin < 10 EU/mL.
- Safety: PCR-based detection of Replication-Competent Adenovirus (RCA).
- Sterility: Mycoplasma, bacteria, and fungi testing.
Applications of Our Services
Precision Cancer Gene Therapy
Our radiation-inducible systems are particularly suited for targeted cancer treatment strategies, where gene expression is activated specifically within irradiated tumor regions.
Typical applications include:
- Radiation-triggered suicide gene therapy (e.g., HSV-TK/GCV systems)
- Localized expression of tumor suppressor genes (e.g., p53, PTEN)
- Controlled delivery of pro-apoptotic or cytotoxic proteins
- Tumor-specific gene activation combined with radiotherapy
👉 Client value: Maximize therapeutic efficacy while minimizing systemic toxicity
Combination Therapy Development
Our vectors are ideal for integration into multi-modal therapeutic strategies.
Applications include:
- Radiotherapy + gene therapy
- Radiation-triggered cytokine or immune modulator expression
- Synergistic approaches with chemotherapy or immunotherapy
👉 Client value: Enable next-generation combination therapies
Tumor Microenvironment Modulation
Radiation-inducible vectors allow localized modulation of the tumor microenvironment (TME).
Examples:
- Expression of anti-angiogenic factors
- Regulation of immune cell recruitment
- Control of cytokine release within tumor sites
👉 Client value: Improve tumor targeting and immune response
Controlled Gene Expression Studies
Beyond therapeutic applications, our systems are highly valuable for basic and translational research.
Use cases include:
- Studying gene function under controlled induction
- Modeling radiation-responsive biological pathways
- Investigating stress-response signaling mechanisms
👉 Client value: High-precision experimental control
Why Choose Creative Biolabs?
01 End-to-End Service Workflow
We provide a fully integrated solution, eliminating the need for multiple vendors.
From concept to delivery, we support:
- Vector design
- Construction and packaging
- Functional validation
- In vitro and in vivo testing
02 High-Quality Viral Production
Our production platform ensures consistency, stability, and high performance.
- High-titer adenoviral vectors
- Rigorous quality control (QC)
- Scalable production capabilities
03 Comprehensive Validation Capabilities
We don't just deliver vectors—we deliver validated results.
- Radiation induction assays
- Expression kinetics analysis
- Dose-response validation
- In vivo functional evaluation
04 Fully Customized Solutions
Every project is unique. We tailor our services to meet your exact requirements.
- Flexible design options
- Custom gene constructs
- Application-specific optimization
Frequently Asked Questions (FAQ)
Q1: How does radiation activate gene expression?
A: Radiation activates gene expression by inducing cellular stress and DNA damage response pathways, which subsequently trigger key transcription factors such as NF-κB, AP-1, and p53. These factors bind to radiation-responsive promoter elements, initiating transcription of the downstream therapeutic gene. In our platform, we further optimize this process by engineering promoter sensitivity and vector design, ensuring robust and controllable gene expression in response to clinically relevant radiation doses. This enables precise temporal control of gene activation, particularly valuable for cancer radiotherapy applications.
Q2: Which promoters are commonly used in radiation-inducible systems?
A: The Egr-1 promoter is the most widely used due to its well-characterized radiation responsiveness and strong inducibility. In addition, NF-κB-responsive promoters and synthetic radiation-inducible promoters are also employed to achieve different activation profiles. At Creative Biolabs, we offer custom promoter selection and engineering services, allowing optimization based on your specific application. This includes tuning promoter sensitivity, minimizing basal leakage, and enhancing inducibility to achieve a balanced and reliable gene expression response.
Q3: Can these radiation-inducible systems be used in vivo?
A: Yes. Radiation-inducible adenoviral vectors have been extensively validated in in vivo models, particularly in oncology research where localized radiation can precisely trigger gene expression at tumor sites. We support both in vitro and in vivo validation workflows, including biodistribution analysis and expression profiling, to ensure your system performs reliably under physiological conditions. These systems also show strong potential for clinical translation, especially in combination with radiotherapy-based treatment strategies.
Q4: How do you ensure specificity of gene expression?
A: Specificity is achieved through a combination of spatial control (localized radiation exposure) and genetic control (promoter design and vector targeting). By restricting radiation delivery to specific tissues, gene activation is confined to the irradiated region. Additionally, we further enhance specificity through promoter engineering, capsid modification, and optional tissue-specific regulatory elements, minimizing off-target expression. This multi-layered strategy ensures precise and controlled gene expression, which is critical for both research accuracy and therapeutic safety.
Connect with Us Anytime!
Creative Biolabs offers a broad range of adenovirus vector construction service at a reasonable cost and with quick turnaround time. Our highly experienced scientists are on hand to solve any difficulties in your adenoviral vector construction projects. Please feel free to contact us for more information.
Reference
- O'Cathail Sean, M.; et al. (2017). Combining Oncolytic Adenovirus with Radiation-A Paradigm for the Future of Radiosensitization. Frontiers in Oncology. 7:153. https://doi.org/10.3389/fonc.2017.00153 Distributed under Open Access license CC BY 4.0, without modification.
